Enhanced COPD Management in Suspected Lung Cancer Patients
Key facts
- Where
- Vejle, DenmarkSee the site
Where in Denmark
- Lung Cancer Investigation Unit, Lillebaelt Hospital VejleVejle, DenmarkTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Ditte Krag-Hansen
- Trial code
- NCT07543601
- Record updated
- 22 April 2026
- Original description
Identifying and treating COPD in patients undergoing lung cancer evaluation is crucial. Early intervention could lead to better management of both diseases, improving health status, reducing healthcare costs, and potentially increasing survival rates.Read full original descriptionShow less
Enhanced COPD Management in Suspected Lung Cancer Patients - Improving Outcomes Through Timely Intervention
Identifying and treating COPD in patients undergoing lung cancer evaluation is crucial. Early intervention could lead to better management of both diseases, improving health status, reducing healthcare costs, and potentially increasing survival rates.
This study aims to assess the impact of early diagnosis and optimal treatment of COPD on clinical outcomes in patients under evaluation for lung cancer. The study will combine information through an open-label RCT at the Lung Cancer Investigation Unit at Lillebaelt Hospital Vejle.
The findings could inform clinical practice by emphasizing the importance of integrated care approaches for patients with coexisting COPD and lung cancer, ultimately leading to better health outcomes.
Inclusion: Undergoing diagnostic evaluation for suspected lung cancer; Spirometry showing obstructive airflow limitation (FEV₁/FVC < 75 % or FEV₁ < 80 %, and no reversibility) at the first outpatient visit at the lung cancer evaluation.
Exclusion: Presence of significant comorbidities that may interfere with diagnostic procedures or spirometry; Pregnant or breastfeeding women.